The positive Q3 financial results indicate a strong performance by Organogenesis Holdings, which typically instills investor confidence and can lead to a short-term increase in stock price. The issuance of FY23 revenue guidance further supports the potential for continued growth, which can have a positive impact on investor sentiment and the stock's short-term trajectory.